Quality of Life in Brain Tumor Patients: The Relative Contributions of Depression, Fatigue, Emotional Distress, and Existential Issues
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Neuropsychiatric problems, and how they interact to impact on quality of life (QOL) in brain tumor patients, are generally poorly understood. The objectives of this study were: (1) to document the prevalence of depression, fatigue, emotional distress, and existential issues in a sample of brain tumor patients (2) to examine the interconnectedness of these problems, and (3) to explore their relationship with disease-related variables and QOL. This is a cross-sectional, questionnaire-based survey of 73 patients with primary brain tumors who presented to a neurological clinic at a tertiary cancer centre for ongoing care. Data for 60 participants (29 women, 31 men) who completed validated questionnaires were retained for analysis. Results showed that there was a high burden of depressive symptoms as measured by the Beck Depression Inventory-II (mean score 11.1, SD 7.4), with 38% of the sample scoring in the clinically depressed range. Overall QOL scores for this sample were similar to a reference sample of brain tumor patients. The scores on the existential subscale of the McGill Quality of Life questionnaire were comparable to those of a reference sample of cancer patients receiving ongoing care (mean score 7.2; SD 1.7). Fifty per cent of the sample could be classified as struggling with existential issues. Although scores reflecting depression, fatigue, emotional distress, and existential problems were interrelated, the presence of depressive symptoms was the single most import…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prevalence rates of existential distress in patients with terminal cancer vary from 3 to 29%, depending on the operationalization of the concept”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Pelletier et al., 2002
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 4×
“Overall, the results obtained by the patients in this study do not differ significantly from those obtained by FACT-BR normative sample [25] or from the scores obtained by the normative sample for the FACT-G [33] (none of the t-tests were significant) (Table 3).”
MethodResultInfluentialThe Psychology of Religion and Coping: Theory Research Practice
Barrett, J. L., & Pargament, K. I. (1998) · Review of Religious Research · doi:10.2307/3512468 · Cited by 2,610
The Psychology of Religion and Coping
McFadden, S. H., & Pargament, K. I. (1998) · Journal for the Scientific Study of Religion · doi:10.2307/1387534 · Cited by 1,441
Decision making during serious illness: What role do patients really want to play?
Degner, L. F., & Sloan, J. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90110-9 · Cited by 1,008 · cited 3×
“Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues Guy Pelletier1, Marja J. Verhoef2, Nasreen Khatri3 and Neil Hagen4,5,6 1Department of Psychosocial Resources, Tom Baker Cancer Centre, 2Department of Community Health Sciences, 3Depart…”
MethodInfluentialFine, H. A., Dear, K. B. G., Loeffler, J. S., Mc Black, P. L., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2585::aid-cncr2820710825>3.0.co;2-s · Cited by 864 · cited 1×
“For example, even with aggressive radiation and chemotherapy regimes, the median survival for patients with grade 4 astrocytoma (glioblastoma multiforme or GBM) is about 12 months, and for grade 3 gliomas it is about 36 months [4].”
BackgroundA case for including spirituality in quality of life measurement in oncology
Brady, M. J., Peterman, A. H., Fitchett, G., Mo, M., & Cella, D. (1999) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199909/10)8:5<417::aid-pon398>3.0.co;2-4 · Cited by 835 · cited 1×
“[20] found that spirituality as measured by the functional assessment of chronic illness therapyspirituality (FACIT-Sp) correlated with general QOL to the same extent as physical well-being.”
BackgroundCohen, S. R., Mount, B. M., Strobel, M. G., & Bui, F. (1995) · Palliative Medicine · doi:10.1177/026921639500900306 · Cited by 738 · cited 9×
“This 7-item subscale is part of the MQOL, a multidimensional QOL questionnaire designed for use at all phases of the disease trajectory in patients with life-threatening diseases.”
MethodInfluentialPsychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001) · Health Psychology · doi:10.1037/0278-6133.20.2.112 · Cited by 694 · cited 1×
“A recent study demonstrated the validity and the usefulness of the BDI-II in the detection of depression in primary care medical patients [27].”
Background
Research works printed but not linked: 3
- Beck A, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. The Psychological Corporation, New York, 1996
- Craighead WE, Craighead L, Ilardi SS: Psychosocial treatments for major depressive disorder. In: Nathan PE, Gorman JM (eds) A Guide to Treatments that Work. Oxford University Press, New York, 1998, pp 226-239
- Simpson S: Management of depression in cancer patients. Perspectives in Depression 8: 1-5, 2000
Cited by
Items 101–200 of 374
Zhou, Y., Peng, Y., Sun, W., Wang, J., Zhang, G., Zhen, L., Ren, X., Wang, A., Lin, S., Chan, M. T. V., et al. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005752 · Cited by 47
Frequency of depression among oncology outpatients and association with other symptoms
Rhondali, W., Perceau-Chambard, É., Berthiller, J., Saltel, P., Trillet-Lenoir, V. N., Trédan, O., Coulon, J.-P., Bruera, E. D., & Filbet, M. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1401-3 · Cited by 52
Boele, F. W., Meads, D. M., Jansen, F., Leeuw, I. M. V., Heimans, J. J., Reijneveld, J. C., Short, S. C., & Klein, M. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03454-3 · Cited by 49
Campanella, F., Palese, A., Missier, F. D., Moreale, R., Ius, T., Shallice, T., Fabbro, F., & Škrap, M. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.04.006 · Cited by 49
“, the feeling of threat to one’s own conception of meaning, purpose, and satisfaction with life) is common at different stages of illness progression,(17) with greater existential distress being linked to depression and poorer QoL.(20) As a consequence, a comprehensive quantitative assessment of psychological function…”
BackgroundRehabilitation of Adult Patients with Primary Brain Tumors: A Narrative Review
Thakkar, P., Greenwald, B. D., & Patel, P. S. (2020) · Brain Sciences · doi:10.3390/brainsci10080492 · Cited by 53
“Fatigue has also been shown to be correlated with existential distress, which is present in this population at meaningful rates (25%) [16].”
BackgroundIrving, G. J., & Lloyd‐Williams, M. (2010) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2010.01.026 · Cited by 51
“and prolongs hospitalization (Breitbart, 1995; Pelletier, 2002).”
BackgroundBultz, B. D., Waller, A. E., Cullum, J., Jones, P., Halland, J., Groff, S. L., Leckie, C., Shirt, L., Blanchard, S., Lau, H., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0147 · Cited by 44
Bulloch, A. G. M., Fiest, K. M., Williams, J. V. A., Lavorato, D. H., Berzins, S. A., Jetté, N., Pringsheim, T. M., & Patten, S. B. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.06.007 · Cited by 46
“Use of the same instrument in n=73 patients attending a tertiary cancer center in Canada showed 38% scoring in the depressed range using the BDI [43], and a study in the USA in a similar clinical setting found 28% of depressed patients using DSM-IV criteria [44].”
MethodMainio, A., Hakko, H. H., Niemelä, A., Koivukangas, J. P., & Räsänen, P. K. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.05.006 · Cited by 42
“The prevalence of depressive symptoms has varied rom 5% to 44% in different samples of patients with a malignant r benign primary brain tumor [1–6].”
BackgroundResultImpairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma
Solanki, C., Sadana, D., Arivazhagan, A., Rao, K. V. L. N., Rajeswaran, J., Subbakrishna, D. K., Santosh, V., & Pandey, P. (2017) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.203829 · Cited by 42
“Similarly, fatigue is reported to be the most common symptom in patients with brain tumors in general.[14] Steinbach et al.”
BackgroundAdmiraal, J. M., van Nuenen, F. M., Burgerhof, J. G. M., Reyners, A. K. L., & Hoekstra‐Weebers, J. E. H. M. (2016) · Psycho-Oncology · doi:10.1002/pon.4067 · Cited by 43
“Elevated distress levels have been associated with reduced health-related quality of life [3,4], low satisfaction with medical care [5] and decreased treatment adherence [6].”
BackgroundLeonetti, A., Puglisi, G., Rossi, M., Viganò, L., Nibali, M. C., Gay, L. G., Sciortino, T., Howells, H., Fornia, L., Riva, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.662039 · Cited by 41
Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
Qureshi, M., Zelinski, E. L., & Carlson, L. E. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735418762496 · Cited by 42
Quality of life and brain tumors: what beyond the clinical burden?
Gıovagnolı, A. R., Meneses, R. F., Silvani, A., Milanesi, I. M., Fariselli, L., Salmaggi, A., & Boiardi, A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7273-3 · Cited by 39
Singer, S., Roick, J., Danker, H., Kortmann, R., Papsdorf, K., Taubenheim, S., Renovanz, M., Jähne, K., & Meixensberger, J. (2018) · Acta Neurochirurgica · doi:10.1007/s00701-018-3527-7 · Cited by 39
Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life
Maitre, P., & Jalali, R. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0808-0 · Cited by 38
Sleep disturbances in adult survivors of childhood brain tumors
Nolan, V. G., Gapstur, R., Gross, C. R., DeSain, L. A., Neglia, J. P., Gajjar, A. J., Klosky, J. L., Merchant, T. E., Stovall, M., & Ness, K. K. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0208-5 · Cited by 36
Young, J. S., Al-Adli, N. N., Sibih, Y., Scotford, K. L., Casey, M., James, S., & Berger, M. S. (2022) · Journal of neurosurgery · doi:10.3171/2022.9.jns221139 · Cited by 35
Palese, A., Cecconi, M., Moreale, R., & Škrap, M. (2012) · Stress and Health · doi:10.1002/smi.2472 · Cited by 38
Agency, Autonomy and Euthanasia
Mendz, G. L., & Kissane, D. W. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520958881 · Cited by 37
Improving customer well-being through two-way online social support
Zheng, Q., Yao, T., & Fan, X. (2016) · Journal of Service Theory and Practice · doi:10.1108/jstp-09-2014-0188 · Cited by 36
Prevalence and correlates of fatigue in patients with meningioma before and after surgery
van der Linden, S. D., Gehring, K., Rutten, G.-J. M., Kop, W. J., & Sitskoorn, M. M. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz023 · Cited by 32
Suicidal ideation and attempts in brain tumor patients and survivors: A systematic review
Mofatteh, M., Mashayekhi, M. S., Arfaie, S., Chen, Y., Malhotra, A. K., Alvi, M. A., Sader, N., Antonick, V., Fatehi, M., Mansouri, A., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad058 · Cited by 31
Cognitive strategies and quality of life of patients with high-grade glioma
Lucchiari, C., Botturi, A., Silvani, A., Lamperti, E., Gaviani, P., Innocenti, A., Finocchiaro, C. Y., Masiero, M. A., & Pravettoni, G. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2691-z · Cited by 31
“Many patients find it difficult to activate a proper coping strategy due to specific factors, such as available cognitive resources, gender-related characteristics, and psychological status [7, 8].”
BackgroundResultNeuro-oncology and palliative care: a challenging interface
Lin, E., Rosenthal, M. A., Le, B. H. C., & Eastman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos209 · Cited by 31
Bao, Y., Li, L., Guan, Y., Wang, W., Liu, Y., Wang, P., Huang, X., Tao, S., & Wang, Y. (2016) · Psycho-Oncology · doi:10.1002/pon.4128 · Cited by 31
“affirmed that depressive symptoms are a prevalent, serious clinical issue for patients with brain tumor and indicated that the presence of depressive symptoms was the single most important predictor of quality of life [8].”
BackgroundAnalysis of psychosocial stress factors in patients with renal cancer
Draeger, D. L., Sievert, K., & Hakenberg, O. W. (2018) · Therapeutic Advances in Urology · doi:10.1177/1756287218754766 · Cited by 32
Umezaki, S., Shinoda, Y., Mukasa, A., Tanaka, S., Takayanagi, S., Oka, H., Tagawa, H., Haga, N., & Yoshino, M. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa068 · Cited by 30
Employment and Work Ability of Persons With Brain Tumors: A Systematic Review
Silvaggi, F., Leonardi, M., Raggi, A., Eigenmann, M., Mariniello, A., Silvani, A., Lamperti, E., & Schiavolin, S. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.571191 · Cited by 32
“, 2017) and associated to a worse health related quality of life (HRQoL) (Pelletier et al., 2002; McCarty et al., 2017).”
BackgroundA Biobehavioral Perspective on Depressive Symptoms in Patients With Cerebral Astrocytoma
Starkweather, A. R., Sherwood, P. R., Lyon, D., McCain, N. L., Bovbjerg, D. H., & Broaddus, W. C. (2011) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3182029859 · Cited by 34
Jacobs, D. I., Kumthekar, P., Stell, B. V., Grimm, S. A., Rademaker, A. W., Rice, L., Chandler, J. P., Muro, K., Marymont, M., Helenowski, I. B., et al. (2014) · Neuro-Oncology Practice · doi:10.1093/nop/npu004 · Cited by 29
“1), which is highly consistent with scores reported in previous studies of QOL in glioma.(3,24) Although our analysis suggested that patients in this study reported total FACT-Br scores that were on average 4.”
ResultLoughan, A. R., Willis, K. D., Braun, S. E., Rodin, G., Lanoye, A., Davies, A. E., Svikis, D., Mazzeo, S., Malkin, M., & Thacker, L. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-03988-8 · Cited by 29
Psychosocial distress among oncology patients in the safety net
Cimino, T., Said, K., Safier, L., Harris, H. A., & Kinderman, A. L. (2020) · Psycho-Oncology · doi:10.1002/pon.5525 · Cited by 29
Tsay, S., Chang, J.-Y., Yates, P. M., Lin, K., & Liang, S. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-1053-0 · Cited by 29
“Depression was the most notable single predictor of QOL among brain tumor patients, with depressed patients more likely to have lower QOL [3].”
BackgroundMedical Management of Patients With Brain Tumors
Pruitt, A. A. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0132-y · Cited by 29
Distress persists in long-term brain tumor survivors with glioblastoma multiforme
Keir, S. T., Farland, M. M., Lipp, E., & Friedman, H. S. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0069-7 · Cited by 29
“... and medications not covered by insurance [18], one’s ability to drive is often suspended which impacts patients’ independence and often increases the sense of burden on social network, changes in body image due to corticosteroid use—cushingoid appearance along with weight gain, tensions in intimate relationships,…”
BackgroundLombardi, G., Bergo, E., Bianco, P. D., Bellu, L., Pambuku, A., Caccese, M., Trentin, L., & Zagonel, V. (2018) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000459 · Cited by 31
Kangas, M., Williams, J. R., & Smee, R. I. (2011) · Applied Research in Quality of Life · doi:10.1007/s11482-011-9159-1 · Cited by 32
“Notwithstanding the limitations from previous MGM research, several studies have demonstrated that between 30% and 68% of patients may be struggling to come to terms with their MGM diagnosis and treatment related side-effects (Kalkanis et al. 2000; Mathiesen et al. 2003; Pelletier et al. 2002).”
MethodRees, J. H. (2002) · Current Opinion in Neurology · doi:10.1097/01.wco.0000044760.39452.71 · Cited by 29
The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes
Madhusoodanan, S., Ting, M. B., & Wilson, S. Y. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00016-2 · Cited by 28
Medical Management of Patients With Brain Tumors
Pruitt, A. A. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464172.50638.21 · Cited by 28
Recurrent brain tumour: the impact of illness on patient's life
Lamperti, E., Pantaleo, G., Finocchiaro, C. Y., Silvani, A., Botturi, A., Gaviani, P., Sarno, L., & Salmaggi, A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1220-y · Cited by 27
“Some studies suggest that depression may be a significant predictor of quality of life in people with brain tumours [27, 28].”
BackgroundJones, S., Ownsworth, T., & Shum, D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00071 · Cited by 27
Conley, C. C., Kamen, C. S., Heckler, C. E., Janelsins, M. C., Morrow, G. R., Peppone, L. J., Scalzo, A. J., Gross, H. M., Dakhil, S. R., Mustian, K. M., et al. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000442 · Cited by 27
Levels of Stress and Intervention Preferences of Caregivers of Brain Tumor Patients
Keir, S. T. (2007) · Cancer Nursing · doi:10.1097/01.ncc.0000300174.18584.f9 · Cited by 26
Program Preferences to Reduce Stress in Caregivers of Patients With Brain Tumors
Swartz, J. J., & Keir, S. T. (2007) · Clinical journal of oncology nursing · doi:10.1188/07.cjon.723-727 · Cited by 30
Factors Associated With Depression in Disease-Free Stomach Cancer Survivors
Han, K. H., Hwang, I. C., Kim, S., Bae, J.-M., Kim, Y., Ryu, K. W., Lee, J. H., Noh, J. H., Sohn, T.-S., Shin, D. W., et al. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.10.234 · Cited by 26
“7% were at least 21.(14) More women (49%) than men (42%) had high depression scores.”
BackgroundPu, C., Tian, S., He, S., Chen, W., He, Y., Ren, H., Zhu, J., Tang, J., Huang, X., Xiang, Y., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.11.013 · Cited by 26
Interventions for the management of fatigue in adults with a primary brain tumour
Day, J., Yust‐Katz, S., Cachia, D., Wefel, J. S., Lukats, I. W. T., Bulbeck, H., & Rooney, A. G. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011376.pub3 · Cited by 28
Milbury, K., Whisenant, M., Weathers, S.-P. S., Mallaiah, S., Snyder, S., Jackson, N. A., Li, J., Li, Y., Silva, R. F., Shih, Y. T., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5514 · Cited by 24
Symptom Prevalence and Management of Cancer Patients in Lebanon
Abu‐Saad, H. H., Abboud, S., & Doumit, M. A. A. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.10.019 · Cited by 28
“Presence of depressive symptoms was the single most important independent predictor of QoL in brain tumor patients.(15) Cancer patients experience a great number of distressing physical and psychological symptoms.”
BackgroundQualitative Longitudinal Analysis of Symptoms in Patients with Primary and Metastatic Brain Tumours
Rijmen, F., Ip, E. H., Rapp, S. R., & Shaw, E. G. (2008) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2008.00529.x · Cited by 24
The burden of a brain tumor: guiding patient centric care in neuro-oncology
Loughan, A. R., Reid, M. P., Willis, K. D., Davies, A., Boutté, R. L., Barrett, S., & Lo, K. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-03993-x · Cited by 23
“Existential concerns have been associated with increased mental health concerns such as depression [47] as well as health related quality of life [48], overall functional capability, and factors such as treatment adherence [47].”
BackgroundSzpringer, M., Oledzka, M., & Amann, B. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00785 · Cited by 22
“Interestingly, a study conducted by Pelletier et al. (2002) demonstrated that intensification of depressive symptoms in patients with brain tumors is even significantly higher than in patients with other types of cancer.”
BackgroundPalliative care at the end-of-life in glioma patients
Koekkoek, J. A. F., Chang, S. M., & TAPHOORN, M. J. B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00019-0 · Cited by 22
Psychooncological distress in low-grade glioma patients—a monocentric study
Ley, A., Kamp, M. A., von Saß, C., Hänggi, D., Sabel, M., & Rapp, M. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04863-7 · Cited by 22
Affective Symptoms and White Matter Changes in Brain Tumor Patients
Richter, A., Woernle, C. M., Krayenbühl, N., Kollias, S. S., & Bellut, D. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.05.031 · Cited by 23
Boele, F. W., Leeuw, I. M. V., Cuijpers, P. J., Reijneveld, J. C., Heimans, J. J., & Klein, M. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-81 · Cited by 24
“Moreover, depression is the most important independent predictor of HRQOL in patients with brain tumors [23].”
BackgroundPeng, Y., Zhang, W., Zhou, X., Ji, Y., Kass, I. S., & Han, R. (2015) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000171 · Cited by 22
Hoffmann, K., Kamp, M. A., Steiger, H., Sabel, M., & Rapp, M. (2017) · Oncotarget · doi:10.18632/oncotarget.22802 · Cited by 22
“A prevalence of depressive symptoms in 15-38% in these patients is reported [3, 4].”
BackgroundSurvivorship care planning and implementation in neuro-oncology
Leeper, H. E., & Milbury, K. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy110 · Cited by 22
Faarup, I., Lauridsen, J. T., Lütgen, K., Nørregaard, A., Poulsen, F. R., & Østergaard, B. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14777 · Cited by 22
“The dysfunction is related to a combination of various factors such as tumour location and its spread, tumour-related epilepsy, treatment and patient-related factors such as age and psychological stress (Stupp et al., 2005; Pelletier et al., 2002).”
BackgroundDeath anxiety in patients with primary brain tumor: Measurement, prevalence, and determinants
Loughan, A. R., Husain, M., Ravyts, S. G., Willis, K. D., Braun, S. E., Brechbiel, J. K., Aslanzadeh, F. J., Rodin, G., Svikis, D. S., & Thacker, L. R. (2021) · Palliative & Supportive Care · doi:10.1017/s1478951521000808 · Cited by 22
“It is not surprising that thoughts of mortality are provoked following a diagnosis of cancer; however, a preoccupation with the fear of death is associated with decreased quality of life, medical nonadherence, and poorer health outcomes (DiMatteo et al., 2000; Pelletier et al., 2002; Randazzo et al., 2017; Shi et al.,…”
BackgroundWang, Y., Bao, Y., Liu, L., Ramos, A., Wang, Y., & Wang, L. (2015) · Psycho-Oncology · doi:10.1002/pon.3838 · Cited by 22
Ozier, D., & Cashman, R. L. (2016) · Canadian Oncology Nursing Journal · doi:10.5737/23688076262104111 · Cited by 21
Lang, S., Cadeaux, M., Opoku-Darko, M., Gaxiola‐Valdez, I., Partlo, L. A., Goodyear, B. G., Federico, P., & Kelly, J. J. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.12.061 · Cited by 22
Röttgering, J. G., Douw, L., Hamer, P. C. D. W., Kouwenhoven, M. C. M., Würdinger, T., van de Ven, P. M., Sharpe, L., Knoop, H., & Klein, M. (2022) · Trials · doi:10.1186/s13063-022-06485-5 · Cited by 21
“The set of secondary outcomes consists of several symptoms, quality of life and level of functioning measured by questionnaires at baseline, after 14 weeks and in follow-up, including depression, HRQOL and anxiety.”
BackgroundInfluentialQuality of life and physical limitations in primary brain tumor patients
Gazzotti, M. R., Malheiros, S. M. F., Alith, M. B., Nascimento, O. A., Santoro, I. L., Jardim, J. R., & Vidotto, M. C. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9908-5 · Cited by 25
“Over the last years, publications regarding QoL in braintumor patients have increased [3, 4, 8, 11].”
BackgroundLoughan, A. R., Braun, S. E., & Lanoye, A. M. (2018) · Neuro-Oncology Practice · doi:10.1093/nop/npy050 · Cited by 20
Bao, Y., Li, L., Guan, Y., Liu, Y., Wang, W., Zhao, D., Tao, S., Ling, Y., Wang, Y., Bi, B., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4321-z · Cited by 21
Baba, M. A., & Adali, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1900 · Cited by 20
“Same results were reported by a previous study showing that the presence of depressive symptoms was the most important independent predictor of QoL in patients with malignant brain tumor (71).”
ResultPalliative care and quality of life in neuro-oncology
Mummudi, N. B., & Jalali, R. (2014) · F1000Prime Reports · doi:10.12703/p6-71 · Cited by 19
The Prevalence of Depression in People with Cancer
Massie, M. J., Lloyd‐Williams, M., Irving, G. J., & Miller, K. (2010) · Wiley eBooks · doi:10.1002/9780470972533.ch1 · Cited by 28
Rumalla, K., Lin, M. P., Orloff, E. A., Ding, L., Zada, G., Mack, W. J., & Attenello, F. J. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.07.048 · Cited by 18
Ownsworth, T., Cubis, L., Prasad, T., Foote, M. C., Kendall, M. B., Oram, J., Chambers, S. K., & Pinkham, M. B. (2020) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2020.1826331 · Cited by 19
“Up to 50% of people with a brain tumour experience existential distress (Pelletier et al., 2002), which often relates to uncertainly about the future, fear about leaving loved ones and struggling to find meaning in one’s changed life situation (Cavers et al., 2012; Ownsworth et al., 2011).”
BackgroundLibert, Y., Merckaert, I., Étienne, A.-M., Farvacques, C., Liénard, A., Messin, S., Meunier, J., Milani, M., Moucheux, A., Reynaert, C., et al. (2006) · ONCOLOGIE · doi:10.1007/s10269-006-0439-6 · Cited by 20
“Non traitée, la détresse peut avoir des conséquences à long terme sur l’adhésion du patient aux traitements [40], sur sa durée d’hospitalisation [63], sur ses chances de survie [20, 35], sur son désir d’un décès anticipé [4] et sur sa qualité de vie ainsi que celle de ses proches [30, 58, 80].”
Coping with the Unthinkable: Psychosocial Advances in the Management of Primary Brain Tumour
Ownsworth, T. (2016) · Brain Impairment · doi:10.1017/brimp.2016.19 · Cited by 19
Sekely, A. W., Bernstein, L. J., Campbell, K. L., Mason, W. P., Laperrière, N., Kalidindi, N., Or, R., Ramos, R., Climans, S., Pond, G. R., et al. (2022) · Neuro-Oncology Practice · doi:10.1093/nop/npac068 · Cited by 17
Li, R., Su, L., Hua, Y., Ye, J., Song, X., Tian, J., Song, J., & Hong, J. (2021) · European Journal of Cancer Care · doi:10.1111/ecc.13487 · Cited by 18
Caring for patients with brain tumor: The patient and care giver perspectives
Mezue, W., Draper, P., Watson, R., & Mathew, B. (2011) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.86786 · Cited by 17
Naughton, M. J., Case, L. D., Peiffer, A. M., Chan, M. D., Stieber, V. W., Moore, D., Falchuk, S. C., Piephoff, J. V., Edenfield, W. J., Giguere, J. K., et al. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npx016 · Cited by 19
“Anaplastic oligodendroglioma 8 (12) 8 (12) Characteristic Donepezil No.”
BackgroundSelecting antiepileptic drugs for symptomatic patients with brain tumors.
Thompson, D. S., Takeshita, J., Thompson, T., & Mulligan, M. (2006) · PubMed · Cited by 17
Depresión y cáncer: una revisión orientada a la práctica clínica
Rodríguez, V. P., Amboage, A. M., Blázquez, M. H., Torres, M. Á. G., & Gaviria, M. (2015) · Revista Colombiana de Cancerología · doi:10.1016/j.rccan.2015.04.005 · Cited by 38
Study of Association of Various Psychiatric Disorders in Brain Tumors
Sharma, A., Das, A. K., Jain, A., Purohit, D. K., Solanki, R. K., & Gupta, A. (2022) · Asian Journal of Neurosurgery · doi:10.1055/s-0042-1757437 · Cited by 16
Quality of life in patients with right‐ or left‐sided brain tumours: literature review
Palese, A., Lamanna, F., Monte, C. D., Calligaris, S., Doretto, M., & Criveller, M. (2008) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2007.02182.x · Cited by 16
Oncology Social Work for Survivorship
Fobair, P. (2007) · Springer eBooks · doi:10.1007/978-0-387-68265-5_3 · Cited by 18
Zahid, N., Martins, R. S., Zahid, W., Khalid, W., Azam, I., Bhamani, S. S., Asad, N., Ahmad, K., Jabbar, A. A., Shamim, M. S., et al. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00354-6 · Cited by 16
Keng, A., Stewart, D. E., & Sheehan, K. (2020) · Psychosomatics · doi:10.1016/j.psym.2019.12.008 · Cited by 15
Supportive management of patients with brain tumors
Daly, F. N., & Schiff, D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1327 · Cited by 15
Anxiety and depression disorders in cancer patients: incidence, diagnosis and therapy
Fischer, D., & Wedel, B. (2012) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-012-0327-2 · Cited by 20
Imaging cerebral tryptophan metabolism in brain tumor-associated depression
Bosnyák, E., Kamson, D. O., Behen, M. E., Barger, G. R., Mittal, S., & Juhász, C. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0136-9 · Cited by 17
“One theory involves an abnormal psychological reaction to overwhelming stress and loss [8, 12].”
Preventing Depression in Later Life: State of the Art and Science Circa 2011
Hindi, F., Dew, M. A., Albert, S. M., Lotrich, F. E., & Reynolds, C. F. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.008 · Cited by 14
Admiraal, J. M., Hoekstra‐Weebers, J. E. H. M., Schröder, C. P., Tuinier, W., Hospers, G. A. P., & Reyners, A. K. L. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05030-6 · Cited by 14
Pidani, A. S., Siddiqui, A. R., Azam, I., Shamim, M. S., Jabbar, A. A., & Khan, S. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032748 · Cited by 14
Ernster, A. E., Body, A., Deleyrolle, P., Clair, J. S., Sampson, D., Bacharz, K. C., Yan, S. C., Melnick, K. F., Allen, A., Rahman, M., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04469-2 · Cited by 13
“Anxious and depressive symptomatology may have downstream adverse effects on immunity and tumorigenesis, and depression is a predictor of cancer mortality [3–6].”
BackgroundWong, S. S., Case, L. D., Avis, N. E., Cummings, T. L., Cramer, C. K., & Rapp, S. R. (2019) · Psycho-Oncology · doi:10.1002/pon.5202 · Cited by 14
“functions,(2) and they have a negative impact on health‐related quality of life (HRQoL) and daily functioning.(3,4) Thus, preservation of cognitive functioning is a top priority for survivors.”
BackgroundKitselaar, W. M., de Morree, H. M., Trompenaars, M. W., Sitskoorn, M. M., Rutten, G.-J. M., & Kop, W. J. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110766 · Cited by 14
Zahid, N., Martins, R. S., Brown, N., Zahid, W., Azam, I., Hassan, A., Ahmad, K., Bhamani, S. S., Jabbar, A. A., Asad, N., et al. (2023) · BMC Research Notes · doi:10.1186/s13104-023-06358-3 · Cited by 13
“strongly with poorer QoL in patients with PBTs [6].”
BackgroundLoquai, C., Scheurich, V., Syring, N., Schmidtmann, I. M., Müller-Brenne, T., Werner, A., Grabbe, S., & Beutel, M. E. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12361 · Cited by 14
Schipmann, S., Molina, E. S., Frasch, A., Stummer, W., & Wiewrodt, D. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2670-y · Cited by 14
Metadata
- Authors
- Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N.
- Affiliations
- University of Calgary (CA)
- ORCID
- Hagen, Neil
- Venue
- Journal of Neuro-Oncology
- Published
- 2002-03
- Volume
- 57
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W1574260815
- Cited by
- 362
- References
- 49
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 17 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 23 · 2019: 16 · 2018: 26 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 12 · 2013: 19 · 2012: 20
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Owens Foundation
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- quality of life, brain tumors, depression, fatigue, emotional distress, existential questions, neuropsychiatric symptoms, primary brain tumors, prevalence of depressive symptoms, McGill Quality of Life Questionnaire, predictors of quality of life
- MeSH terms
- Adult, Affective Symptoms, Brain Neoplasms, Depression, Fatigue, Female, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Regression Analysis, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.